12 Biggest Mid-Day Losers For Monday

Comments
Loading...
  • China Commercial Credit Inc CCCR dropped 14.8 percent to $2.41 after climbing 11.42 percent on Friday.
  • Great Basin Scientific Inc GBSN shares dipped 13.3 percent to $0.98 on Q1 results. Great Basin Scientific posted Q1 net income of $21,503,600, versus a year-ago net loss of $33,652,500.
  • NetSol Technologies Inc. NTWK fell 12.2 percent to $3.95. NetSol Technology posted Q3 earnings of $0.06 per share on sales of $17.9 million. The company also issued a weak sales forecast for FY 2017.
  • Quorum Health Corp QHC shares dropped 11.5 percent to $3.53.
  • Diana Containerships Inc DCIX tumbled 8.3 percent to $0.431. Diana Containerships reported a Q1 loss of $0.80 per share on sales of $3.77 million.
  • National Grid plc (ADR) NGG shares declined 7.7 percent to $69.41 after surging 10.50 percent on Friday.
  • Interpace Diagnostics Group Inc IDXG dropped 7.6 percent to $2.18 after the company filed for up to $13.8 million stock offering.
  • GlycoMimetics Inc GLYC shares declined 7.1 percent to $11.86 after surging 19.59 percent on Friday.
  • Synchronoss Technologies, Inc. SNCR shares slipped 7 percent to $12.60. Credit Suisse downgraded Synchronoss Technologies from Neutral to Underperform.
  • Zoe's Kitchen Inc ZOES dropped 6.7 percent to $16.97. Baird downgraded Zoe's Kitchen from Outperform to Neutral.
  • Momenta Pharmaceuticals, Inc. MNTA fell 5.6 percent to $14.68. Barclays downgraded Momenta Pharmaceuticals from Overweight to Equal-Weight.
  • La Jolla Pharmaceutical Company LJPC shares declined 3.5 percent to $32.79 after the company released Phase 3 results in the New England Journal of Medicine from a study called ATHOS-3, which evaluated the company's therapy LJPC-501 for the treatment of patients with catecholamine resistant hypotension (CRH).
Market News and Data brought to you by Benzinga APIs
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm

Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!